Shexiang Tongxin dropping pill protects against isoproterenol-induced myocardial ischemia <i>in vivo</i> and <i>in vitro</i>.

导出 OA

翻译打印收藏纠错

作者： Jianyong,Qi ^[1] ; Wenjun,Pan ^[2] ; Yafang,Tan ^[1] ; Jiaru,Luo ^[2] ; Dancai,Fan ^[1] ; Juan,Yu ^[2] ; Jiashin,Wu ^[1] ; Minzhou,Zhang ^[2]

作者单位： AMI Key Laboratory of Chinese Medicine in Guangzhou, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, Guangzhou 510006, China. ^[1] Intensive Care Research Team of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, Guangzhou 510006, China. ^[2] Animal Center, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, Guangzhou 510006, China. ^[3] Department of Pharmaceutical Sciences, College of Pharmacy, Northeast Ohio Medical University, Rootstown, Ohio 44272, USA. ^[4]

关键词 Shexiang Tongxin dropping pill isoproterenol myocardial ischemia rat signaling pathway

DOI 10.18632/oncotarget.22440

PMID 29312582

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交